Found 578 hits with Last Name = 'milligan' and Initial = 'd' Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
Vascular endothelial growth factor receptor 2
(Homo sapiens (Human)) | BDBM50211992
(CHEMBL236419 | N-(4-(chlorodifluoromethoxy)phenyl)...)Show SMILES FC(F)(Cl)Oc1cccc(NC(=O)c2ccnn2CCc2ccncc2)c1 Show InChI InChI=1S/C18H15ClF2N4O2/c19-18(20,21)27-15-3-1-2-14(12-15)24-17(26)16-6-10-23-25(16)11-7-13-4-8-22-9-5-13/h1-6,8-10,12H,7,11H2,(H,24,26) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 70 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Chemical Diversity, Inc.
Curated by ChEMBL
| Assay Description Inhibition of VEGFR2 assessed as inhibition of phosphorylation in presence of 2 uM ATP by HTRF assay |
Bioorg Med Chem Lett 17: 3550-7 (2007)
Article DOI: 10.1016/j.bmcl.2007.04.042 BindingDB Entry DOI: 10.7270/Q2MG7P6N |
More data for this Ligand-Target Pair | |
Vascular endothelial growth factor receptor 2
(Homo sapiens (Human)) | BDBM50211983
(1-(2-(pyridin-4-yl)ethyl)-N-(4-(trifluoromethoxy)p...)Show InChI InChI=1S/C18H15F3N4O2/c19-18(20,21)27-15-3-1-14(2-4-15)24-17(26)16-7-11-23-25(16)12-8-13-5-9-22-10-6-13/h1-7,9-11H,8,12H2,(H,24,26) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 80 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Chemical Diversity, Inc.
Curated by ChEMBL
| Assay Description Displacement of [32P]ATP from human VEGFR2 after 45 mins |
Bioorg Med Chem Lett 17: 3550-7 (2007)
Article DOI: 10.1016/j.bmcl.2007.04.042 BindingDB Entry DOI: 10.7270/Q2MG7P6N |
More data for this Ligand-Target Pair | |
Vascular endothelial growth factor receptor 2
(Homo sapiens (Human)) | BDBM50211983
(1-(2-(pyridin-4-yl)ethyl)-N-(4-(trifluoromethoxy)p...)Show InChI InChI=1S/C18H15F3N4O2/c19-18(20,21)27-15-3-1-14(2-4-15)24-17(26)16-7-11-23-25(16)12-8-13-5-9-22-10-6-13/h1-7,9-11H,8,12H2,(H,24,26) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 90 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Chemical Diversity, Inc.
Curated by ChEMBL
| Assay Description Inhibition of VEGFR2 assessed as inhibition of phosphorylation in presence of 2 uM ATP by HTRF assay |
Bioorg Med Chem Lett 17: 3550-7 (2007)
Article DOI: 10.1016/j.bmcl.2007.04.042 BindingDB Entry DOI: 10.7270/Q2MG7P6N |
More data for this Ligand-Target Pair | |
Vascular endothelial growth factor receptor 2
(Homo sapiens (Human)) | BDBM50211992
(CHEMBL236419 | N-(4-(chlorodifluoromethoxy)phenyl)...)Show SMILES FC(F)(Cl)Oc1cccc(NC(=O)c2ccnn2CCc2ccncc2)c1 Show InChI InChI=1S/C18H15ClF2N4O2/c19-18(20,21)27-15-3-1-2-14(12-15)24-17(26)16-6-10-23-25(16)11-7-13-4-8-22-9-5-13/h1-6,8-10,12H,7,11H2,(H,24,26) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 90 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Chemical Diversity, Inc.
Curated by ChEMBL
| Assay Description Displacement of [32P]ATP from human VEGFR2 after 45 mins |
Bioorg Med Chem Lett 17: 3550-7 (2007)
Article DOI: 10.1016/j.bmcl.2007.04.042 BindingDB Entry DOI: 10.7270/Q2MG7P6N |
More data for this Ligand-Target Pair | |
Vascular endothelial growth factor receptor 2
(Homo sapiens (Human)) | BDBM50211976
(CHEMBL397323 | N-(4-chlorophenyl)-1-(2-(pyridin-4-...)Show InChI InChI=1S/C17H15ClN4O/c18-14-1-3-15(4-2-14)21-17(23)16-7-11-20-22(16)12-8-13-5-9-19-10-6-13/h1-7,9-11H,8,12H2,(H,21,23) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 90 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Chemical Diversity, Inc.
Curated by ChEMBL
| Assay Description Displacement of [32P]ATP from human VEGFR2 after 45 mins |
Bioorg Med Chem Lett 17: 3550-7 (2007)
Article DOI: 10.1016/j.bmcl.2007.04.042 BindingDB Entry DOI: 10.7270/Q2MG7P6N |
More data for this Ligand-Target Pair | |
Vascular endothelial growth factor receptor 2
(Homo sapiens (Human)) | BDBM50211976
(CHEMBL397323 | N-(4-chlorophenyl)-1-(2-(pyridin-4-...)Show InChI InChI=1S/C17H15ClN4O/c18-14-1-3-15(4-2-14)21-17(23)16-7-11-20-22(16)12-8-13-5-9-19-10-6-13/h1-7,9-11H,8,12H2,(H,21,23) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 110 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Chemical Diversity, Inc.
Curated by ChEMBL
| Assay Description Inhibition of VEGFR2 assessed as inhibition of phosphorylation in presence of 2 uM ATP by HTRF assay |
Bioorg Med Chem Lett 17: 3550-7 (2007)
Article DOI: 10.1016/j.bmcl.2007.04.042 BindingDB Entry DOI: 10.7270/Q2MG7P6N |
More data for this Ligand-Target Pair | |
Vascular endothelial growth factor receptor 2
(Homo sapiens (Human)) | BDBM50211979
(CHEMBL399605 | N-(4-tert-butylphenyl)-1-(2-(pyridi...)Show InChI InChI=1S/C21H24N4O/c1-21(2,3)17-4-6-18(7-5-17)24-20(26)19-10-14-23-25(19)15-11-16-8-12-22-13-9-16/h4-10,12-14H,11,15H2,1-3H3,(H,24,26) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 130 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Chemical Diversity, Inc.
Curated by ChEMBL
| Assay Description Inhibition of VEGFR2 assessed as inhibition of phosphorylation in presence of 2 uM ATP by HTRF assay |
Bioorg Med Chem Lett 17: 3550-7 (2007)
Article DOI: 10.1016/j.bmcl.2007.04.042 BindingDB Entry DOI: 10.7270/Q2MG7P6N |
More data for this Ligand-Target Pair | |
Vascular endothelial growth factor receptor 2
(Homo sapiens (Human)) | BDBM50211979
(CHEMBL399605 | N-(4-tert-butylphenyl)-1-(2-(pyridi...)Show InChI InChI=1S/C21H24N4O/c1-21(2,3)17-4-6-18(7-5-17)24-20(26)19-10-14-23-25(19)15-11-16-8-12-22-13-9-16/h4-10,12-14H,11,15H2,1-3H3,(H,24,26) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 140 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Chemical Diversity, Inc.
Curated by ChEMBL
| Assay Description Displacement of [32P]ATP from human VEGFR2 after 45 mins |
Bioorg Med Chem Lett 17: 3550-7 (2007)
Article DOI: 10.1016/j.bmcl.2007.04.042 BindingDB Entry DOI: 10.7270/Q2MG7P6N |
More data for this Ligand-Target Pair | |
Vascular endothelial growth factor receptor 2
(Homo sapiens (Human)) | BDBM50211972
(CHEMBL233823 | N-(3-chloro-4-(trifluoromethyl)phen...)Show SMILES FC(F)(F)c1ccc(NC(=O)c2ccnn2CCc2ccncc2)cc1Cl Show InChI InChI=1S/C18H14ClF3N4O/c19-15-11-13(1-2-14(15)18(20,21)22)25-17(27)16-5-9-24-26(16)10-6-12-3-7-23-8-4-12/h1-5,7-9,11H,6,10H2,(H,25,27) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 160 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Chemical Diversity, Inc.
Curated by ChEMBL
| Assay Description Displacement of [32P]ATP from human VEGFR2 after 45 mins |
Bioorg Med Chem Lett 17: 3550-7 (2007)
Article DOI: 10.1016/j.bmcl.2007.04.042 BindingDB Entry DOI: 10.7270/Q2MG7P6N |
More data for this Ligand-Target Pair | |
Vascular endothelial growth factor receptor 2
(Homo sapiens (Human)) | BDBM50211972
(CHEMBL233823 | N-(3-chloro-4-(trifluoromethyl)phen...)Show SMILES FC(F)(F)c1ccc(NC(=O)c2ccnn2CCc2ccncc2)cc1Cl Show InChI InChI=1S/C18H14ClF3N4O/c19-15-11-13(1-2-14(15)18(20,21)22)25-17(27)16-5-9-24-26(16)10-6-12-3-7-23-8-4-12/h1-5,7-9,11H,6,10H2,(H,25,27) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 170 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Chemical Diversity, Inc.
Curated by ChEMBL
| Assay Description Inhibition of VEGFR2 assessed as inhibition of phosphorylation in presence of 2 uM ATP by HTRF assay |
Bioorg Med Chem Lett 17: 3550-7 (2007)
Article DOI: 10.1016/j.bmcl.2007.04.042 BindingDB Entry DOI: 10.7270/Q2MG7P6N |
More data for this Ligand-Target Pair | |
Vascular endothelial growth factor receptor 2
(Homo sapiens (Human)) | BDBM84749
(N-(3-methylphenyl)-2-(pyridin-4-ylmethylamino)benz...)Show InChI InChI=1S/C20H19N3O/c1-15-5-4-6-17(13-15)23-20(24)18-7-2-3-8-19(18)22-14-16-9-11-21-12-10-16/h2-13,22H,14H2,1H3,(H,23,24) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 15 | n/a | n/a | n/a | n/a | 7.5 | 25 |
ChemDiv Inc.
| Assay Description In a representative synthetic procedure (compound 3), a mixture of 1 (330 mg, 2 mM) and 3-F3C-C6H4-NHNH2 (370 mg, 2.1 mM) in anisole (20 mL) was stir... |
Chem Biol Drug Des 69: 331-7 (2007)
Article DOI: 10.1111/j.1747-0285.2007.00507.x BindingDB Entry DOI: 10.7270/Q2DR2T12 |
More data for this Ligand-Target Pair | |
Vascular endothelial growth factor receptor 2
(Homo sapiens (Human)) | BDBM50179883
((4-Isopropylphenyl)-(4-isoquinolin-5-yl-phthalazin...)Show SMILES CC(C)c1ccc(Nc2nnc(-c3cccc4cnccc34)c3ccccc23)cc1 Show InChI InChI=1S/C26H22N4/c1-17(2)18-10-12-20(13-11-18)28-26-24-8-4-3-7-23(24)25(29-30-26)22-9-5-6-19-16-27-15-14-21(19)22/h3-17H,1-2H3,(H,28,30) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 17 | n/a | n/a | n/a | n/a | n/a | n/a |
ImClone Systems
Curated by ChEMBL
| Assay Description Inhibition of VEGFR2 by HTRF assay |
Bioorg Med Chem Lett 16: 1579-81 (2006)
Article DOI: 10.1016/j.bmcl.2005.12.045 BindingDB Entry DOI: 10.7270/Q2WS8SVC |
More data for this Ligand-Target Pair | |
Vascular endothelial growth factor receptor 2
(Homo sapiens (Human)) | BDBM50179883
((4-Isopropylphenyl)-(4-isoquinolin-5-yl-phthalazin...)Show SMILES CC(C)c1ccc(Nc2nnc(-c3cccc4cnccc34)c3ccccc23)cc1 Show InChI InChI=1S/C26H22N4/c1-17(2)18-10-12-20(13-11-18)28-26-24-8-4-3-7-23(24)25(29-30-26)22-9-5-6-19-16-27-15-14-21(19)22/h3-17H,1-2H3,(H,28,30) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 17 | n/a | n/a | n/a | n/a | n/a | n/a |
ImClone Systems, Inc.
Curated by ChEMBL
| Assay Description Inhibition of VEGFR2 (unknown origin) by HTRF method |
Bioorg Med Chem 17: 731-40 (2009)
Article DOI: 10.1016/j.bmc.2008.11.049 BindingDB Entry DOI: 10.7270/Q2W95929 |
More data for this Ligand-Target Pair | |
Vascular endothelial growth factor receptor 2
(Homo sapiens (Human)) | BDBM50211983
(1-(2-(pyridin-4-yl)ethyl)-N-(4-(trifluoromethoxy)p...)Show InChI InChI=1S/C18H15F3N4O2/c19-18(20,21)27-15-3-1-14(2-4-15)24-17(26)16-7-11-23-25(16)12-8-13-5-9-22-10-6-13/h1-7,9-11H,8,12H2,(H,24,26) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 18 | n/a | n/a | n/a | n/a | n/a | n/a |
Chemical Diversity, Inc.
Curated by ChEMBL
| Assay Description Inhibition of VEGFR2 assessed as inhibition of phosphorylation in human 293 cells by cell-based ELISA |
Bioorg Med Chem Lett 17: 3550-7 (2007)
Article DOI: 10.1016/j.bmcl.2007.04.042 BindingDB Entry DOI: 10.7270/Q2MG7P6N |
More data for this Ligand-Target Pair | |
Vascular endothelial growth factor receptor 2
(Homo sapiens (Human)) | BDBM50211992
(CHEMBL236419 | N-(4-(chlorodifluoromethoxy)phenyl)...)Show SMILES FC(F)(Cl)Oc1cccc(NC(=O)c2ccnn2CCc2ccncc2)c1 Show InChI InChI=1S/C18H15ClF2N4O2/c19-18(20,21)27-15-3-1-2-14(12-15)24-17(26)16-6-10-23-25(16)11-7-13-4-8-22-9-5-13/h1-6,8-10,12H,7,11H2,(H,24,26) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 21 | n/a | n/a | n/a | n/a | n/a | n/a |
Chemical Diversity, Inc.
Curated by ChEMBL
| Assay Description Inhibition of VEGFR2 assessed as inhibition of phosphorylation in human 293 cells by cell-based ELISA |
Bioorg Med Chem Lett 17: 3550-7 (2007)
Article DOI: 10.1016/j.bmcl.2007.04.042 BindingDB Entry DOI: 10.7270/Q2MG7P6N |
More data for this Ligand-Target Pair | |
Vascular endothelial growth factor receptor 2
(Homo sapiens (Human)) | BDBM84747
((B) ZD6474 | US10155768, Vandetanib | US10183928, ...)Show SMILES CN1CCC(COc2cc3ncnc(Nc4ccc(Br)cc4F)c3cc2C)CC1 Show InChI InChI=1S/C23H25BrFN3O/c1-15-9-19-21(10-17-3-4-18(24)11-20(17)25)26-14-27-22(19)12-23(15)29-13-16-5-7-28(2)8-6-16/h3-4,9,11-12,14,16H,5-8,10,13H2,1-2H3 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 22 | n/a | n/a | n/a | n/a | n/a | 25 |
ChemDiv Inc.
| Assay Description In a representative synthetic procedure (compound 3), a mixture of 1 (330 mg, 2 mM) and 3-F3C-C6H4-NHNH2 (370 mg, 2.1 mM) in anisole (20 mL) was stir... |
Chem Biol Drug Des 69: 331-7 (2007)
Article DOI: 10.1111/j.1747-0285.2007.00507.x BindingDB Entry DOI: 10.7270/Q2DR2T12 |
More data for this Ligand-Target Pair | |
Vascular endothelial growth factor receptor 2
(Homo sapiens (Human)) | BDBM50211983
(1-(2-(pyridin-4-yl)ethyl)-N-(4-(trifluoromethoxy)p...)Show InChI InChI=1S/C18H15F3N4O2/c19-18(20,21)27-15-3-1-14(2-4-15)24-17(26)16-7-11-23-25(16)12-8-13-5-9-22-10-6-13/h1-7,9-11H,8,12H2,(H,24,26) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 28 | n/a | n/a | n/a | n/a | n/a | n/a |
Chemical Diversity, Inc.
Curated by ChEMBL
| Assay Description Inhibition of VEGFR2 assessed as inhibition of phosphorylation in presence of 2 uM ATP by HTRF assay |
Bioorg Med Chem Lett 17: 3550-7 (2007)
Article DOI: 10.1016/j.bmcl.2007.04.042 BindingDB Entry DOI: 10.7270/Q2MG7P6N |
More data for this Ligand-Target Pair | |
Vascular endothelial growth factor receptor 2
(Homo sapiens (Human)) | BDBM9543
(((pyridin-4-yl)ethyl)pyridine 25 | N-[4-(chlorodif...)Show SMILES FC(F)(Cl)Oc1ccc(Nc2nnc(o2)-c2cccnc2CCc2ccncc2)cc1 Show InChI InChI=1S/C21H16ClF2N5O2/c22-21(23,24)31-16-6-4-15(5-7-16)27-20-29-28-19(30-20)17-2-1-11-26-18(17)8-3-14-9-12-25-13-10-14/h1-2,4-7,9-13H,3,8H2,(H,27,29) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 31 | n/a | n/a | n/a | n/a | n/a | n/a |
Chemical Diversity, Inc
| Assay Description The assay uses purified enzyme interacting with biotinylated peptide substrate. HTRF is based on the proximity of europium cryptate (donor fluorophor... |
Bioorg Med Chem Lett 16: 1913-9 (2006)
Article DOI: 10.1016/j.bmcl.2005.12.090 BindingDB Entry DOI: 10.7270/Q2C827H5 |
More data for this Ligand-Target Pair | |
Vascular endothelial growth factor receptor 2
(Homo sapiens (Human)) | BDBM9504
(2-[(pyridin-4-ylmethyl)amino]-N-(quinolin-3-yl)ben...)Show InChI InChI=1S/C22H18N4O/c27-22(26-18-13-17-5-1-3-7-20(17)25-15-18)19-6-2-4-8-21(19)24-14-16-9-11-23-12-10-16/h1-13,15,24H,14H2,(H,26,27) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 32 | n/a | n/a | n/a | n/a | n/a | 25 |
ChemDiv Inc.
| Assay Description In a representative synthetic procedure (compound 3), a mixture of 1 (330 mg, 2 mM) and 3-F3C-C6H4-NHNH2 (370 mg, 2.1 mM) in anisole (20 mL) was stir... |
Chem Biol Drug Des 69: 331-7 (2007)
Article DOI: 10.1111/j.1747-0285.2007.00507.x BindingDB Entry DOI: 10.7270/Q2DR2T12 |
More data for this Ligand-Target Pair | |
Vascular endothelial growth factor receptor 2
(Homo sapiens (Human)) | BDBM50211979
(CHEMBL399605 | N-(4-tert-butylphenyl)-1-(2-(pyridi...)Show InChI InChI=1S/C21H24N4O/c1-21(2,3)17-4-6-18(7-5-17)24-20(26)19-10-14-23-25(19)15-11-16-8-12-22-13-9-16/h4-10,12-14H,11,15H2,1-3H3,(H,24,26) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 33 | n/a | n/a | n/a | n/a | n/a | n/a |
Chemical Diversity, Inc.
Curated by ChEMBL
| Assay Description Inhibition of VEGFR2 assessed as inhibition of phosphorylation in human 293 cells by cell-based ELISA |
Bioorg Med Chem Lett 17: 3550-7 (2007)
Article DOI: 10.1016/j.bmcl.2007.04.042 BindingDB Entry DOI: 10.7270/Q2MG7P6N |
More data for this Ligand-Target Pair | |
Vascular endothelial growth factor receptor 2
(Homo sapiens (Human)) | BDBM50211979
(CHEMBL399605 | N-(4-tert-butylphenyl)-1-(2-(pyridi...)Show InChI InChI=1S/C21H24N4O/c1-21(2,3)17-4-6-18(7-5-17)24-20(26)19-10-14-23-25(19)15-11-16-8-12-22-13-9-16/h4-10,12-14H,11,15H2,1-3H3,(H,24,26) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 42 | n/a | n/a | n/a | n/a | n/a | n/a |
Chemical Diversity, Inc.
Curated by ChEMBL
| Assay Description Inhibition of VEGFR2 assessed as inhibition of phosphorylation in presence of 2 uM ATP by HTRF assay |
Bioorg Med Chem Lett 17: 3550-7 (2007)
Article DOI: 10.1016/j.bmcl.2007.04.042 BindingDB Entry DOI: 10.7270/Q2MG7P6N |
More data for this Ligand-Target Pair | |
Vascular endothelial growth factor receptor 2
(Homo sapiens (Human)) | BDBM9537
(((pyridin-4-yl)ethyl)pyridine 19 | N-(4-tert-butyl...)Show SMILES CC(C)(C)c1ccc(Nc2nnc(o2)-c2cccnc2CCc2ccncc2)cc1 Show InChI InChI=1S/C24H25N5O/c1-24(2,3)18-7-9-19(10-8-18)27-23-29-28-22(30-23)20-5-4-14-26-21(20)11-6-17-12-15-25-16-13-17/h4-5,7-10,12-16H,6,11H2,1-3H3,(H,27,29) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 43 | n/a | n/a | n/a | n/a | n/a | n/a |
Chemical Diversity, Inc
| Assay Description The assay uses purified enzyme interacting with biotinylated peptide substrate. HTRF is based on the proximity of europium cryptate (donor fluorophor... |
Bioorg Med Chem Lett 16: 1913-9 (2006)
Article DOI: 10.1016/j.bmcl.2005.12.090 BindingDB Entry DOI: 10.7270/Q2C827H5 |
More data for this Ligand-Target Pair | |
Vascular endothelial growth factor receptor 2
(Homo sapiens (Human)) | BDBM9544
(((pyridin-4-yl)ethyl)pyridine 26 | 5-{2-[2-(pyridi...)Show SMILES FC(F)(F)Oc1ccc(Nc2nnc(o2)-c2cccnc2CCc2ccncc2)cc1 Show InChI InChI=1S/C21H16F3N5O2/c22-21(23,24)31-16-6-4-15(5-7-16)27-20-29-28-19(30-20)17-2-1-11-26-18(17)8-3-14-9-12-25-13-10-14/h1-2,4-7,9-13H,3,8H2,(H,27,29) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 44 | n/a | n/a | n/a | n/a | n/a | n/a |
Chemical Diversity, Inc
| Assay Description The assay uses purified enzyme interacting with biotinylated peptide substrate. HTRF is based on the proximity of europium cryptate (donor fluorophor... |
Bioorg Med Chem Lett 16: 1913-9 (2006)
Article DOI: 10.1016/j.bmcl.2005.12.090 BindingDB Entry DOI: 10.7270/Q2C827H5 |
More data for this Ligand-Target Pair | |
Vascular endothelial growth factor receptor 2
(Homo sapiens (Human)) | BDBM21
(CHEMBL24828 | N-(4-bromo-2-fluorophenyl)-6-methoxy...)Show SMILES COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1 Show InChI InChI=1S/C22H24BrFN4O2/c1-28-7-5-14(6-8-28)12-30-21-11-19-16(10-20(21)29-2)22(26-13-25-19)27-18-4-3-15(23)9-17(18)24/h3-4,9-11,13-14H,5-8,12H2,1-2H3,(H,25,26,27) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| Purchase
CHEMBL DrugBank MCE PC cid PC sid PDB UniChem
Similars
| Article PubMed
| n/a | n/a | 45 | n/a | n/a | n/a | n/a | n/a | n/a |
ImClone Systems, Inc.
Curated by ChEMBL
| Assay Description Inhibition of VEGFR2 (unknown origin) by HTRF method |
Bioorg Med Chem 17: 731-40 (2009)
Article DOI: 10.1016/j.bmc.2008.11.049 BindingDB Entry DOI: 10.7270/Q2W95929 |
More data for this Ligand-Target Pair | |
Vascular endothelial growth factor receptor 2
(Homo sapiens (Human)) | BDBM84761
((15) 1H-1,2,4-triazol-3-yl-anilines 3-Br-(C6H4) 4-...)Show InChI InChI=1S/C19H14BrN5/c20-14-4-3-5-16(12-14)25-13-22-19(24-25)17-6-1-2-7-18(17)23-15-8-10-21-11-9-15/h1-13H,(H,21,23) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 46 | n/a | n/a | n/a | n/a | 7.5 | 25 |
ChemDiv Inc.
| Assay Description In a representative synthetic procedure (compound 3), a mixture of 1 (330 mg, 2 mM) and 3-F3C-C6H4-NHNH2 (370 mg, 2.1 mM) in anisole (20 mL) was stir... |
Chem Biol Drug Des 69: 331-7 (2007)
Article DOI: 10.1111/j.1747-0285.2007.00507.x BindingDB Entry DOI: 10.7270/Q2DR2T12 |
More data for this Ligand-Target Pair | |
Vascular endothelial growth factor receptor 2
(Homo sapiens (Human)) | BDBM50179881
((4-Chlorophenyl)-(4-isoquinolin-5-yl-phthalazin-1-...)Show SMILES Clc1ccc(Nc2nnc(-c3cccc4cnccc34)c3ccccc23)cc1 Show InChI InChI=1S/C23H15ClN4/c24-16-8-10-17(11-9-16)26-23-21-6-2-1-5-20(21)22(27-28-23)19-7-3-4-15-14-25-13-12-18(15)19/h1-14H,(H,26,28) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 48 | n/a | n/a | n/a | n/a | n/a | n/a |
ImClone Systems
Curated by ChEMBL
| Assay Description Inhibition of VEGFR2 by HTRF assay |
Bioorg Med Chem Lett 16: 1579-81 (2006)
Article DOI: 10.1016/j.bmcl.2005.12.045 BindingDB Entry DOI: 10.7270/Q2WS8SVC |
More data for this Ligand-Target Pair | |
Vascular endothelial growth factor receptor 2
(Homo sapiens (Human)) | BDBM50179881
((4-Chlorophenyl)-(4-isoquinolin-5-yl-phthalazin-1-...)Show SMILES Clc1ccc(Nc2nnc(-c3cccc4cnccc34)c3ccccc23)cc1 Show InChI InChI=1S/C23H15ClN4/c24-16-8-10-17(11-9-16)26-23-21-6-2-1-5-20(21)22(27-28-23)19-7-3-4-15-14-25-13-12-18(15)19/h1-14H,(H,26,28) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 48 | n/a | n/a | n/a | n/a | n/a | n/a |
ImClone Systems, Inc.
Curated by ChEMBL
| Assay Description Inhibition of VEGFR2 (unknown origin) by HTRF method |
Bioorg Med Chem 17: 731-40 (2009)
Article DOI: 10.1016/j.bmc.2008.11.049 BindingDB Entry DOI: 10.7270/Q2W95929 |
More data for this Ligand-Target Pair | |
Vascular endothelial growth factor receptor 2
(Homo sapiens (Human)) | BDBM50212000
(1-(2-(pyridin-4-yl)ethyl)-N-(4-(trifluoromethyl)ph...)Show InChI InChI=1S/C18H15F3N4O/c19-18(20,21)14-1-3-15(4-2-14)24-17(26)16-7-11-23-25(16)12-8-13-5-9-22-10-6-13/h1-7,9-11H,8,12H2,(H,24,26) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 48 | n/a | n/a | n/a | n/a | n/a | n/a |
Chemical Diversity, Inc.
Curated by ChEMBL
| Assay Description Inhibition of VEGFR2 assessed as inhibition of phosphorylation in human 293 cells by cell-based ELISA |
Bioorg Med Chem Lett 17: 3550-7 (2007)
Article DOI: 10.1016/j.bmcl.2007.04.042 BindingDB Entry DOI: 10.7270/Q2MG7P6N |
More data for this Ligand-Target Pair | |
Vascular endothelial growth factor receptor 2
(Homo sapiens (Human)) | BDBM84755
((9) 1H-1,2,4-triazol-3-yl-anilines 3-F3CO(C6H4) 4-...)Show SMILES FC(F)(F)Oc1cccc(c1)-n1cnc(n1)-c1ccccc1Nc1ccncc1 Show InChI InChI=1S/C20H14F3N5O/c21-20(22,23)29-16-5-3-4-15(12-16)28-13-25-19(27-28)17-6-1-2-7-18(17)26-14-8-10-24-11-9-14/h1-13H,(H,24,26) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 48 | n/a | n/a | n/a | n/a | 7.5 | 25 |
ChemDiv Inc.
| Assay Description In a representative synthetic procedure (compound 3), a mixture of 1 (330 mg, 2 mM) and 3-F3C-C6H4-NHNH2 (370 mg, 2.1 mM) in anisole (20 mL) was stir... |
Chem Biol Drug Des 69: 331-7 (2007)
Article DOI: 10.1111/j.1747-0285.2007.00507.x BindingDB Entry DOI: 10.7270/Q2DR2T12 |
More data for this Ligand-Target Pair | |
Vascular endothelial growth factor receptor 2
(Homo sapiens (Human)) | BDBM9538
(((pyridin-4-yl)ethyl)pyridine 20 | N-[4-(propan-2-...)Show SMILES CC(C)c1ccc(Nc2nnc(o2)-c2cccnc2CCc2ccncc2)cc1 Show InChI InChI=1S/C23H23N5O/c1-16(2)18-6-8-19(9-7-18)26-23-28-27-22(29-23)20-4-3-13-25-21(20)10-5-17-11-14-24-15-12-17/h3-4,6-9,11-16H,5,10H2,1-2H3,(H,26,28) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 51 | n/a | n/a | n/a | n/a | n/a | n/a |
Chemical Diversity, Inc
| Assay Description The assay uses purified enzyme interacting with biotinylated peptide substrate. HTRF is based on the proximity of europium cryptate (donor fluorophor... |
Bioorg Med Chem Lett 16: 1913-9 (2006)
Article DOI: 10.1016/j.bmcl.2005.12.090 BindingDB Entry DOI: 10.7270/Q2C827H5 |
More data for this Ligand-Target Pair | |
Vascular endothelial growth factor receptor 2
(Homo sapiens (Human)) | BDBM50211981
(CHEMBL236420 | N-(4-isopropylphenyl)-1-(2-(pyridin...)Show InChI InChI=1S/C20H22N4O/c1-15(2)17-3-5-18(6-4-17)23-20(25)19-9-13-22-24(19)14-10-16-7-11-21-12-8-16/h3-9,11-13,15H,10,14H2,1-2H3,(H,23,25) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 53 | n/a | n/a | n/a | n/a | n/a | n/a |
Chemical Diversity, Inc.
Curated by ChEMBL
| Assay Description Inhibition of VEGFR2 assessed as inhibition of phosphorylation in human 293 cells by cell-based ELISA |
Bioorg Med Chem Lett 17: 3550-7 (2007)
Article DOI: 10.1016/j.bmcl.2007.04.042 BindingDB Entry DOI: 10.7270/Q2MG7P6N |
More data for this Ligand-Target Pair | |
Vascular endothelial growth factor receptor 2
(Homo sapiens (Human)) | BDBM4851
((4-chlorophenyl)-[4-(4-pyridylmethyl)phthalazin-1-...)Show InChI InChI=1S/C20H15ClN4/c21-15-5-7-16(8-6-15)23-20-18-4-2-1-3-17(18)19(24-25-20)13-14-9-11-22-12-10-14/h1-12H,13H2,(H,23,25) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| Purchase
CHEMBL DrugBank MCE PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 54 | n/a | n/a | n/a | n/a | n/a | 25 |
ChemDiv Inc.
| Assay Description In a representative synthetic procedure (compound 3), a mixture of 1 (330 mg, 2 mM) and 3-F3C-C6H4-NHNH2 (370 mg, 2.1 mM) in anisole (20 mL) was stir... |
Chem Biol Drug Des 69: 331-7 (2007)
Article DOI: 10.1111/j.1747-0285.2007.00507.x BindingDB Entry DOI: 10.7270/Q2DR2T12 |
More data for this Ligand-Target Pair | |
Vascular endothelial growth factor receptor 2
(Homo sapiens (Human)) | BDBM9545
(((pyridin-4-yl)ethyl)pyridine 27 | 5-{2-[2-(pyridi...)Show SMILES FC(F)(F)c1ccc(Nc2nnc(o2)-c2cccnc2CCc2ccncc2)cc1 Show InChI InChI=1S/C21H16F3N5O/c22-21(23,24)15-4-6-16(7-5-15)27-20-29-28-19(30-20)17-2-1-11-26-18(17)8-3-14-9-12-25-13-10-14/h1-2,4-7,9-13H,3,8H2,(H,27,29) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 58 | n/a | n/a | n/a | n/a | n/a | n/a |
Chemical Diversity, Inc
| Assay Description The assay uses purified enzyme interacting with biotinylated peptide substrate. HTRF is based on the proximity of europium cryptate (donor fluorophor... |
Bioorg Med Chem Lett 16: 1913-9 (2006)
Article DOI: 10.1016/j.bmcl.2005.12.090 BindingDB Entry DOI: 10.7270/Q2C827H5 |
More data for this Ligand-Target Pair | |
Vascular endothelial growth factor receptor 2
(Homo sapiens (Human)) | BDBM84757
((11) 1H-1,2,4-triazol-3-yl-anilines 3-tBu-(C6H4) 4...)Show SMILES CC(C)(C)c1cccc(c1)-n1cnc(n1)-c1ccccc1Nc1ccncc1 Show InChI InChI=1S/C23H23N5/c1-23(2,3)17-7-6-8-19(15-17)28-16-25-22(27-28)20-9-4-5-10-21(20)26-18-11-13-24-14-12-18/h4-16H,1-3H3,(H,24,26) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 59 | n/a | n/a | n/a | n/a | 7.5 | 25 |
ChemDiv Inc.
| Assay Description In a representative synthetic procedure (compound 3), a mixture of 1 (330 mg, 2 mM) and 3-F3C-C6H4-NHNH2 (370 mg, 2.1 mM) in anisole (20 mL) was stir... |
Chem Biol Drug Des 69: 331-7 (2007)
Article DOI: 10.1111/j.1747-0285.2007.00507.x BindingDB Entry DOI: 10.7270/Q2DR2T12 |
More data for this Ligand-Target Pair | |
Vascular endothelial growth factor receptor 2
(Homo sapiens (Human)) | BDBM84750
((3) 1H-1,2,4-triazol-3-yl-anilines)Show SMILES FC(F)(F)c1cccc(c1)-n1cnc(n1)-c1ccccc1Nc1ccncc1 Show InChI InChI=1S/C20H14F3N5/c21-20(22,23)14-4-3-5-16(12-14)28-13-25-19(27-28)17-6-1-2-7-18(17)26-15-8-10-24-11-9-15/h1-13H,(H,24,26) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 62 | n/a | n/a | n/a | n/a | 7.5 | 25 |
ChemDiv Inc.
| Assay Description In a representative synthetic procedure (compound 3), a mixture of 1 (330 mg, 2 mM) and 3-F3C-C6H4-NHNH2 (370 mg, 2.1 mM) in anisole (20 mL) was stir... |
Chem Biol Drug Des 69: 331-7 (2007)
Article DOI: 10.1111/j.1747-0285.2007.00507.x BindingDB Entry DOI: 10.7270/Q2DR2T12 |
More data for this Ligand-Target Pair | |
Vascular endothelial growth factor receptor 2
(Homo sapiens (Human)) | BDBM9523
(((pyridin-4-yl)ethyl)pyridine 5 | 5-{2-[2-(pyridin...)Show SMILES FC(F)(F)c1cccc(Nc2nnc(o2)-c2cccnc2CCc2ccncc2)c1 Show InChI InChI=1S/C21H16F3N5O/c22-21(23,24)15-3-1-4-16(13-15)27-20-29-28-19(30-20)17-5-2-10-26-18(17)7-6-14-8-11-25-12-9-14/h1-5,8-13H,6-7H2,(H,27,29) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 64 | n/a | n/a | n/a | n/a | 7.5 | 22 |
Chemical Diversity, Inc
| Assay Description The assay uses purified enzyme interacting with biotinylated peptide substrate. HTRF is based on the proximity of europium cryptate (donor fluorophor... |
Bioorg Med Chem Lett 16: 1913-9 (2006)
Article DOI: 10.1016/j.bmcl.2005.12.090 BindingDB Entry DOI: 10.7270/Q2C827H5 |
More data for this Ligand-Target Pair | |
Vascular endothelial growth factor receptor 2
(Homo sapiens (Human)) | BDBM9560
(((pyridin-4-yl)ethyl)pyridine 42 | N-(3,4-dimethox...)Show SMILES COc1ccc(Nc2nnc(o2)-c2cccnc2CCc2ccncc2)cc1OC Show InChI InChI=1S/C22H21N5O3/c1-28-19-8-6-16(14-20(19)29-2)25-22-27-26-21(30-22)17-4-3-11-24-18(17)7-5-15-9-12-23-13-10-15/h3-4,6,8-14H,5,7H2,1-2H3,(H,25,27) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 67 | n/a | n/a | n/a | n/a | n/a | n/a |
Chemical Diversity, Inc
| Assay Description The assay uses purified enzyme interacting with biotinylated peptide substrate. HTRF is based on the proximity of europium cryptate (donor fluorophor... |
Bioorg Med Chem Lett 16: 1913-9 (2006)
Article DOI: 10.1016/j.bmcl.2005.12.090 BindingDB Entry DOI: 10.7270/Q2C827H5 |
More data for this Ligand-Target Pair | |
Vascular endothelial growth factor receptor 1
(Homo sapiens (Human)) | BDBM84761
((15) 1H-1,2,4-triazol-3-yl-anilines 3-Br-(C6H4) 4-...)Show InChI InChI=1S/C19H14BrN5/c20-14-4-3-5-16(12-14)25-13-22-19(24-25)17-6-1-2-7-18(17)23-15-8-10-21-11-9-15/h1-13H,(H,21,23) | PDB MMDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 68 | n/a | n/a | n/a | n/a | 7.5 | 25 |
ChemDiv Inc.
| Assay Description In a representative synthetic procedure (compound 3), a mixture of 1 (330 mg, 2 mM) and 3-F3C-C6H4-NHNH2 (370 mg, 2.1 mM) in anisole (20 mL) was stir... |
Chem Biol Drug Des 69: 331-7 (2007)
Article DOI: 10.1111/j.1747-0285.2007.00507.x BindingDB Entry DOI: 10.7270/Q2DR2T12 |
More data for this Ligand-Target Pair | |
Vascular endothelial growth factor receptor 2
(Homo sapiens (Human)) | BDBM50212000
(1-(2-(pyridin-4-yl)ethyl)-N-(4-(trifluoromethyl)ph...)Show InChI InChI=1S/C18H15F3N4O/c19-18(20,21)14-1-3-15(4-2-14)24-17(26)16-7-11-23-25(16)12-8-13-5-9-22-10-6-13/h1-7,9-11H,8,12H2,(H,24,26) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 69 | n/a | n/a | n/a | n/a | n/a | n/a |
Chemical Diversity, Inc.
Curated by ChEMBL
| Assay Description Inhibition of VEGFR2 assessed as inhibition of phosphorylation in presence of 2 uM ATP by HTRF assay |
Bioorg Med Chem Lett 17: 3550-7 (2007)
Article DOI: 10.1016/j.bmcl.2007.04.042 BindingDB Entry DOI: 10.7270/Q2MG7P6N |
More data for this Ligand-Target Pair | |
Vascular endothelial growth factor receptor 2
(Homo sapiens (Human)) | BDBM9552
(((pyridin-4-yl)ethyl)pyridine 34 | 5-{2-[2-(pyridi...)Show SMILES FC(F)(F)Oc1cccc(Nc2nnc(o2)-c2cccnc2CCc2ccncc2)c1 Show InChI InChI=1S/C21H16F3N5O2/c22-21(23,24)31-16-4-1-3-15(13-16)27-20-29-28-19(30-20)17-5-2-10-26-18(17)7-6-14-8-11-25-12-9-14/h1-5,8-13H,6-7H2,(H,27,29) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 69 | n/a | n/a | n/a | n/a | n/a | n/a |
Chemical Diversity, Inc
| Assay Description The assay uses purified enzyme interacting with biotinylated peptide substrate. HTRF is based on the proximity of europium cryptate (donor fluorophor... |
Bioorg Med Chem Lett 16: 1913-9 (2006)
Article DOI: 10.1016/j.bmcl.2005.12.090 BindingDB Entry DOI: 10.7270/Q2C827H5 |
More data for this Ligand-Target Pair | |
Vascular endothelial growth factor receptor 2
(Homo sapiens (Human)) | BDBM50211981
(CHEMBL236420 | N-(4-isopropylphenyl)-1-(2-(pyridin...)Show InChI InChI=1S/C20H22N4O/c1-15(2)17-3-5-18(6-4-17)23-20(25)19-9-13-22-24(19)14-10-16-7-11-21-12-8-16/h3-9,11-13,15H,10,14H2,1-2H3,(H,23,25) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 74 | n/a | n/a | n/a | n/a | n/a | n/a |
Chemical Diversity, Inc.
Curated by ChEMBL
| Assay Description Inhibition of VEGFR2 assessed as inhibition of phosphorylation in presence of 2 uM ATP by HTRF assay |
Bioorg Med Chem Lett 17: 3550-7 (2007)
Article DOI: 10.1016/j.bmcl.2007.04.042 BindingDB Entry DOI: 10.7270/Q2MG7P6N |
More data for this Ligand-Target Pair | |
Vascular endothelial growth factor receptor 2
(Homo sapiens (Human)) | BDBM50179890
((4-tert-Butylphenyl)-(4-isoquinolin-5-yl-phthalazi...)Show SMILES CC(C)(C)c1ccc(Nc2nnc(-c3cccc4cnccc34)c3ccccc23)cc1 Show InChI InChI=1S/C27H24N4/c1-27(2,3)19-11-13-20(14-12-19)29-26-24-9-5-4-8-23(24)25(30-31-26)22-10-6-7-18-17-28-16-15-21(18)22/h4-17H,1-3H3,(H,29,31) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 75 | n/a | n/a | n/a | n/a | n/a | n/a |
ImClone Systems, Inc.
Curated by ChEMBL
| Assay Description Inhibition of VEGFR2 (unknown origin) by HTRF method |
Bioorg Med Chem 17: 731-40 (2009)
Article DOI: 10.1016/j.bmc.2008.11.049 BindingDB Entry DOI: 10.7270/Q2W95929 |
More data for this Ligand-Target Pair | |
Vascular endothelial growth factor receptor 2
(Homo sapiens (Human)) | BDBM50179890
((4-tert-Butylphenyl)-(4-isoquinolin-5-yl-phthalazi...)Show SMILES CC(C)(C)c1ccc(Nc2nnc(-c3cccc4cnccc34)c3ccccc23)cc1 Show InChI InChI=1S/C27H24N4/c1-27(2,3)19-11-13-20(14-12-19)29-26-24-9-5-4-8-23(24)25(30-31-26)22-10-6-7-18-17-28-16-15-21(18)22/h4-17H,1-3H3,(H,29,31) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 75 | n/a | n/a | n/a | n/a | n/a | n/a |
ImClone Systems
Curated by ChEMBL
| Assay Description Inhibition of VEGFR2 by HTRF assay |
Bioorg Med Chem Lett 16: 1579-81 (2006)
Article DOI: 10.1016/j.bmcl.2005.12.045 BindingDB Entry DOI: 10.7270/Q2WS8SVC |
More data for this Ligand-Target Pair | |
Vascular endothelial growth factor receptor 2
(Homo sapiens (Human)) | BDBM50211976
(CHEMBL397323 | N-(4-chlorophenyl)-1-(2-(pyridin-4-...)Show InChI InChI=1S/C17H15ClN4O/c18-14-1-3-15(4-2-14)21-17(23)16-7-11-20-22(16)12-8-13-5-9-19-10-6-13/h1-7,9-11H,8,12H2,(H,21,23) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 77 | n/a | n/a | n/a | n/a | n/a | n/a |
Chemical Diversity, Inc.
Curated by ChEMBL
| Assay Description Inhibition of VEGFR2 assessed as inhibition of phosphorylation in presence of 2 uM ATP by HTRF assay |
Bioorg Med Chem Lett 17: 3550-7 (2007)
Article DOI: 10.1016/j.bmcl.2007.04.042 BindingDB Entry DOI: 10.7270/Q2MG7P6N |
More data for this Ligand-Target Pair | |
Vascular endothelial growth factor receptor 2
(Homo sapiens (Human)) | BDBM50173019
(4-(4-(4-tert-butylphenylamino)phthalazin-1-yl)benz...)Show SMILES CC(C)(C)c1ccc(Nc2nnc(-c3ccc(cc3)C(N)=O)c3ccccc23)cc1 Show InChI InChI=1S/C25H24N4O/c1-25(2,3)18-12-14-19(15-13-18)27-24-21-7-5-4-6-20(21)22(28-29-24)16-8-10-17(11-9-16)23(26)30/h4-15H,1-3H3,(H2,26,30)(H,27,29) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| Purchase
CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 78 | n/a | n/a | n/a | n/a | n/a | n/a |
ImClone Systems, Inc.
Curated by ChEMBL
| Assay Description Inhibition of VEGFR2 (unknown origin) by HTRF method |
Bioorg Med Chem 17: 731-40 (2009)
Article DOI: 10.1016/j.bmc.2008.11.049 BindingDB Entry DOI: 10.7270/Q2W95929 |
More data for this Ligand-Target Pair | |
Vascular endothelial growth factor receptor 2
(Homo sapiens (Human)) | BDBM50173019
(4-(4-(4-tert-butylphenylamino)phthalazin-1-yl)benz...)Show SMILES CC(C)(C)c1ccc(Nc2nnc(-c3ccc(cc3)C(N)=O)c3ccccc23)cc1 Show InChI InChI=1S/C25H24N4O/c1-25(2,3)18-12-14-19(15-13-18)27-24-21-7-5-4-6-20(21)22(28-29-24)16-8-10-17(11-9-16)23(26)30/h4-15H,1-3H3,(H2,26,30)(H,27,29) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| Purchase
CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 78 | n/a | n/a | n/a | n/a | n/a | n/a |
ImClone Systems
Curated by ChEMBL
| Assay Description Inhibition of Vascular endothelial growth factor receptor 2 kinase phosphorylation of pGAT-biotin peptide |
Bioorg Med Chem Lett 15: 4696-8 (2005)
Article DOI: 10.1016/j.bmcl.2005.07.064 BindingDB Entry DOI: 10.7270/Q25Q4VNS |
More data for this Ligand-Target Pair | |
Vascular endothelial growth factor receptor 2
(Homo sapiens (Human)) | BDBM9559
(((pyridin-4-yl)ethyl)pyridine 41 | N-(3,4-dichloro...)Show SMILES Clc1ccc(Nc2nnc(o2)-c2cccnc2CCc2ccncc2)cc1Cl Show InChI InChI=1S/C20H15Cl2N5O/c21-16-5-4-14(12-17(16)22)25-20-27-26-19(28-20)15-2-1-9-24-18(15)6-3-13-7-10-23-11-8-13/h1-2,4-5,7-12H,3,6H2,(H,25,27) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 79 | n/a | n/a | n/a | n/a | n/a | n/a |
Chemical Diversity, Inc
| Assay Description The assay uses purified enzyme interacting with biotinylated peptide substrate. HTRF is based on the proximity of europium cryptate (donor fluorophor... |
Bioorg Med Chem Lett 16: 1913-9 (2006)
Article DOI: 10.1016/j.bmcl.2005.12.090 BindingDB Entry DOI: 10.7270/Q2C827H5 |
More data for this Ligand-Target Pair | |
Vascular endothelial growth factor receptor 2
(Homo sapiens (Human)) | BDBM50179889
(CHEMBL382818 | N-(4-(chlorodifluoromethoxy)phenyl)...)Show SMILES FC(F)(Cl)Oc1ccc(Nc2nnc(-c3cccc4cnccc34)c3ccccc23)cc1 Show InChI InChI=1S/C24H15ClF2N4O/c25-24(26,27)32-17-10-8-16(9-11-17)29-23-21-6-2-1-5-20(21)22(30-31-23)19-7-3-4-15-14-28-13-12-18(15)19/h1-14H,(H,29,31) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 79 | n/a | n/a | n/a | n/a | n/a | n/a |
ImClone Systems, Inc.
Curated by ChEMBL
| Assay Description Inhibition of VEGFR2 (unknown origin) by HTRF method |
Bioorg Med Chem 17: 731-40 (2009)
Article DOI: 10.1016/j.bmc.2008.11.049 BindingDB Entry DOI: 10.7270/Q2W95929 |
More data for this Ligand-Target Pair | |
Vascular endothelial growth factor receptor 2
(Homo sapiens (Human)) | BDBM50179889
(CHEMBL382818 | N-(4-(chlorodifluoromethoxy)phenyl)...)Show SMILES FC(F)(Cl)Oc1ccc(Nc2nnc(-c3cccc4cnccc34)c3ccccc23)cc1 Show InChI InChI=1S/C24H15ClF2N4O/c25-24(26,27)32-17-10-8-16(9-11-17)29-23-21-6-2-1-5-20(21)22(30-31-23)19-7-3-4-15-14-28-13-12-18(15)19/h1-14H,(H,29,31) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 79 | n/a | n/a | n/a | n/a | n/a | n/a |
ImClone Systems
Curated by ChEMBL
| Assay Description Inhibition of VEGFR2 by HTRF assay |
Bioorg Med Chem Lett 16: 1579-81 (2006)
Article DOI: 10.1016/j.bmcl.2005.12.045 BindingDB Entry DOI: 10.7270/Q2WS8SVC |
More data for this Ligand-Target Pair | |
Vascular endothelial growth factor receptor 2
(Homo sapiens (Human)) | BDBM9562
(((pyridin-4-yl)ethyl)pyridine 44 | N-(2H-1,3-benzo...)Show SMILES C(Cc1ncccc1-c1nnc(NCc2ccc3OCOc3c2)o1)c1ccncc1 Show InChI InChI=1S/C22H19N5O3/c1-2-17(18(24-9-1)5-3-15-7-10-23-11-8-15)21-26-27-22(30-21)25-13-16-4-6-19-20(12-16)29-14-28-19/h1-2,4,6-12H,3,5,13-14H2,(H,25,27) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 85 | n/a | n/a | n/a | n/a | n/a | n/a |
Chemical Diversity, Inc
| Assay Description The assay uses purified enzyme interacting with biotinylated peptide substrate. HTRF is based on the proximity of europium cryptate (donor fluorophor... |
Bioorg Med Chem Lett 16: 1913-9 (2006)
Article DOI: 10.1016/j.bmcl.2005.12.090 BindingDB Entry DOI: 10.7270/Q2C827H5 |
More data for this Ligand-Target Pair | |